MedPath

Genetic and Environmental Risk Factors Related to Esophageal Cancer

Active, not recruiting
Conditions
Esophageal Cancer
Registration Number
NCT01035398
Lead Sponsor
Massachusetts General Hospital
Brief Summary

RATIONALE: Gathering information about genes, cigarette smoking, and diet may help doctors learn more about risk factors that may cause esophageal cancer.

PURPOSE: This clinical trial is studying genetic and environmental risk factors related to esophageal cancer.

Detailed Description

OBJECTIVES:

* Examine the role of several genetically-determined factors in combination with cigarette smoking and diet in the etiology and prevention of esophageal cancer.

* Identify polymorphisms in metabolizing enzymes (e.g., phase I or II metabolism \[GSTM1, GSTT1,CYP1A1, CYP3A5, mEH, NQO1, GSTP1\], DNA repair \[XRCC1, ERCC2\], free-radical formation \[MPO, MnSOD\], inflammatory genes \[ IL1-beta\], metastatic potential \[MMP1\], and cell cycle or tumor suppression \[p21, p53\]) and related path genes of susceptibility for esophageal cancer.

OUTLINE: Blood and tumor tissue samples are collected. DNA purified from these samples is analyzed using DNA-based assays to determine polymorphisms in various related gene pathways.

Patients complete questionnaires concerning environmental, smoking and diet habits.

PROJECTED ACCRUAL: A total of 1,000 tissue samples from patients and healthy participants (750 patients and 250 healthy participants) will be accrued for this study.

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
All
Target Recruitment
1200
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Polymorphisms in various pathways, DNA repair, free-radical formation, inflammatory genes, metastatic potential, and cell cycle or tumor suppression in blood samples2000-2016
Comparison of presence or absence of variant polymorphisms between cases and controls2000-2016
Correlation between polymorphisms in blood samples and polymorphisms in tissue specimens2000-2016
Analyses of dietary factors and Helicobacter pylori infection (previous vs current)2000-2016
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (2)

Massachusetts General Hospital

πŸ‡ΊπŸ‡Έ

Boston, Massachusetts, United States

Harvard School of Public Health

πŸ‡ΊπŸ‡Έ

Boston, Massachusetts, United States

Massachusetts General Hospital
πŸ‡ΊπŸ‡ΈBoston, Massachusetts, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Β© 2025 MedPath, Inc. All rights reserved.